This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Monica Morrow, MD

Arch Surg. 1997;132(5):517.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The demonstration of the effectiveness of a new technology generates great enthusiasm for its use and, with experience and time, a rational role for the technology is usually defined. Since the initial description of SCNB by Parker et al¹ in 1990, the procedure has been widely adopted, and Devia and colleagues propose an algorithm for the evaluation of mammographic abnormalities that includes SCNB as an initial step for any lesion considered too suspicious for short interval follow-up. However, before we adopt SCNB as the "standard of care" in all cases, there are many questions that remain to be answered.

A breast biopsy procedure must reliably determine if a lesion is benign or malignant and accurately characterize malignant lesions to allow definitive therapy. Approximately 50% of the mammographic abnormalities that require biopsy are calcifications, which may be more difficult to target and require a larger number of specimens from core . . . [Full Text PDF of this Article]

Author Affiliations
Northwestern University School of Medicine Chicago, Ill

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?